Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery
Cutting-edge technologies and collaborative research are transforming how scientists overcome genomic instability and accelerate therapeutic protein production
Discover how bit.bio's CRISPR-Ready ioCells eliminate months of cell line development
This assay uses hiPSC‑derived cardiomyocytes with Maestro MEA technology to measure electrophysiology across a functional cardiac syncytium
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responses
New services make patient-specific stem cells more accessible for drug discovery and disease studies
Learn how CancerTools.org is rewriting how cancer research tools move from lab benches to scientists around the world, and how the profits are put straight back into fighting cancer
Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling
Hear how the Ocular Tissue Engineering Laboratory is addressing retinal cell culture challenges via an automated stem cell robot platform
Registration now open
Partnership follows successful scale-up of CHO Edge System by LOTTE BIOLOGICS
Defined stem cell media offers easy transition to clinical manufacturing
Charles River to provide master cell banking and NGS testing services for cord blood derived allogeneic CAR-T cells
The TotalSeq Phenocyte solution supports robust study of cellular heterogeneity and rare cell types in complex samples at a single cell level
New frontiers in glioblastoma: Patient-derived organoids on Axion BioSystems’ Maestro Z impedance-based live-cell analysis system offer new insights into CAR T bioactivity and immunotherapy efficacy
High-throughput platform accelerates drug discovery by reducing the number of manual steps by up to 90%
Successes across the de-extinction pipeline signal that the thylacine project is on track as Colossal continues its global effort to fight the extinction crisis
This guest editorial explores how advances in single-cell technologies to reveal novel insights into hematopoietic development
Discovery advances research into how diabetes impacts and damages blood vessels
Cytovance and Celltheon partner to provide an integrated solution for customers seeking to outsource cell line development through to cGMP manufacturing of mammalian-expressed products
